ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ZNTL Zentalis Pharmaceuticals Inc

12.54
0.00 (0.00%)
プレマーケット
最終更新日: 17:05:01
15分遅延
名称 銘柄コード 市場 種別
Zentalis Pharmaceuticals Inc ZNTL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 12.54 17:05:01
始値 安値 高値 終値 前日終値
12.54
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0720:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0720:03EDGAR2Form 8-K - Current report
2024/5/0720:00GLOBEZentalis Pharmaceuticals Reports First Quarter 2024..
2024/5/0206:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
2024/4/0305:05GLOBEZentalis Pharmaceuticals to Highlight Preclinical Data..
2024/4/0206:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
2024/3/0208:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
2024/3/0107:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0107:14EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/2/2821:00GLOBEZentalis Pharmaceuticals to Participate in Upcoming Investor..
2024/2/2721:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2721:04EDGAR2Form 8-K - Current report
2024/2/2721:00GLOBEZentalis Pharmaceuticals Reports Full Year 2023 Financial..
2024/2/1606:12EDGAR2Form 8-K - Current report
2024/2/1409:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1321:00GLOBEZentalis Pharmaceuticals to Participate in the Oppenheimer..
2024/2/1310:25EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1310:25EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1310:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0311:29EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0311:29EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0311:28EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0311:27EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0311:26EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0207:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
2024/1/2521:03EDGAR2Form 8-K - Current report
2024/1/2521:00GLOBEZentalis Pharmaceuticals Strengthens Management Team with..
2024/1/0821:03EDGAR2Form 8-K - Current report
2024/1/0821:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
2024/1/0410:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0410:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0306:49GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
2023/12/2207:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0207:39GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
2023/11/1407:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1407:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0921:00GLOBEZentalis to Participate in Investor Call Focused on Ovarian..
2023/11/0623:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0623:04EDGAR2Form 8-K - Current report
2023/11/0621:18GLOBEZentalis Pharmaceuticals Reports Third Quarter 2023..
2023/11/0205:52GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
2023/10/0708:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0708:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0708:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0706:00EDGAR2Form 8-K - Current report
2023/10/0509:28EDGAR2Form 144 - Report of proposed sale of securities

最近閲覧した銘柄

Delayed Upgrade Clock